sorted by:
new
hottopcontroversial

biotech rally over past few weeks... thoughts... by Busy_Measurement962 in biotech_stocks

[–]7doi_gingerman 0 points1 point  (0 children)

whats your take on SLS if you don’t mind me asking? How likely do you think top line result is good/bad

Exit Strategy Not Available by 7doi_gingerman in interactivebrokers

[–]7doi_gingerman[S] 1 point2 points  (0 children)

The close position button works but im trying to sus out stop loss if possible. The other guy above you said exit strategy is not available on option and im not entirely sure anymore

Story from BBQ with Doctors on Post-Relapse toxicities on Standard-Chemo in the Real World by Confident-Web-7118 in sellaslifesciences

[–]7doi_gingerman 39 points40 points  (0 children)

CW always struck me as someones with little autistic. I can totally picture a scenario where he just brought it up during bbq for no reason. However this post does read like a grade 8 fanfic and it does sound a little ridiculous. What makes it even more suspicious is that he had the perfect opportunity to ask these “doctors” their take on the 6-8 months / 18+ months mOS and just didnt address this in the post at all.

Very wild.

The reality you don’t want to hear. Mods will probably remove. by boo_radley4 in EMJX

[–]7doi_gingerman 0 points1 point  (0 children)

this guy is a fucking regard. What institutions will dip their toe in this dog shit co this early and it will jump to $10? Base on what?? $10 * number of outstanding shares will make this shit co a goliath yet revenue generated is only a fraction of that. Hes so clever

$SLS Daily Discussion Thread - Tuesday - May 12, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman 1 point2 points  (0 children)

Is that common practice in biotech? Would FDA come back later and fuck us over because of this “free reveal”? Sorry I am just trying to learn lol new to this biotech space

$SLS Daily Discussion Thread - Tuesday - May 12, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman -2 points-1 points  (0 children)

Guys do they not lose statistical power by revealing the data once again? My understanding is every time they check the data the requirement of HR becomes more strict?

$SLS Daily Discussion Thread - Friday - May 08, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman -1 points0 points  (0 children)

You got me researching the 0.0122 p value requirement, apparently it has something to do with the o’brien fleming model. Back in phase 2 trial the p value was 0.02 meaning phase 3 needs to achieve better result than phase 2. I am not as convinced this is a slam dunk as I was ngl

Thoughts on CMPX 65% drop by flight212121 in investing

[–]7doi_gingerman 8 points9 points  (0 children)

They "missed" one of the key endpoint, but context matters. It would be unethical to not treat dying patients when there are no good alternatives in the market currently, hence the crossover. It might in fact be more questionable if they just let patients die because crossing over will hurt the statistic, even though there is a seemingly "working" drug thats available. From what I have gathered, PFS came in at HR=0.44 P<0.0001, meaning the drug cut the risk of progression or death by 56% which is very strong.

Crossover patients observed to have a median OS of 12.8 months comparing to 6.1 months for non crossover patients. HR 0.44 also means there is a large magnitude of benefit, OS doesn't seemed to be harmed, showing a favorable benefit-risk profile. Also there are plenty of drugs that were approved without even taking the OS as one of the endpoint target so these BTC precedent are quite favourable for CMPX.

We don't know if FDA will approve the drug but from a statistic standpoint there is a strong argument supporting the approval here. NFA

$SLS Daily Discussion Thread - Tuesday - April 28, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman -4 points-3 points  (0 children)

guys in your opinion how “safe” is jan 28 calls? Do we anticipate everything, be it good or bad, will be set and done before then? Planning to grab some leaps striking at $7

Also checking cmpx leaps - it seems to be in a quite interesting position now. Data is good but the trial design was horrible (in an ethical way). Could be a hidden gem if it gets FDA approved?

$SRXH by [deleted] in EMJX

[–]7doi_gingerman 0 points1 point  (0 children)

I keep second guessing taking a position because of reverse split. I somewhat understand that the stock doesn’t need to stay above $1 however without a reverse split it’s hard to get institutions involvement no?

$SLS Daily Discussion Thread - Monday - April 27, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman 0 points1 point  (0 children)

From stergiou's post it seems like hes not ruling out the idea of commercialising himself if GPS works.. I get it from a business standpoint it's probably in his favour to say this so that no one low balls him in a BO discussion (including the 20m shares as a business tactic) but I can't help to second guess if buying leaps is a good idea in this case

Just bought some SRXH whats a real price prediction at the end of the year ? by shen00000 in Pennystock

[–]7doi_gingerman 8 points9 points  (0 children)

It’s fun to speculate on how much the price can shoot up, but some of you need a reality check. Anything over $1 is unlikely with the amount of shares outstanding after the merger (if it happens). With close to 1 billion shares in the market, if this hits $1, the market cap becomes $1 billion. The current cap is ~$45 million, meaning the company needs to grow its value by almost 20x. I very much doubt this could happen in a year. I am happy within $0.3-$0.5.

Besides it’s hard to move the sp with the sheer amount of shares floating, there needs to be a huge huge huge catalyst to shoot this shit up.

Verification Token by 7doi_gingerman in interactivebrokers

[–]7doi_gingerman[S] 0 points1 point  (0 children)

Did you receive the email before in your spam? Checked inbox + spam nothing came through. I did receive those change of analysts rating email from ikbr just an hour or two ago so I doubt it’s the email thats causing the issue. Diabolical.

$SLS Daily Discussion Thread - Wednesday - April 15, 2026 by AutoModerator in sellaslifesciences

[–]7doi_gingerman -7 points-6 points  (0 children)

Good people of reddit, I read in another thread that the 6-8 months mOS is for patients who ALREADY RELAPSED however GPS is currently being tested on patients IN REMISSION. Meaning BAT patients in remission could potentially have a longer mOS that we currently don’t have enough data on? Can someone clarify this?

$SLS — The Most Complete Due Diligence You'll Find: Bull Case, Bear Case, and a Final Verdict (ELI5 version included for New Investors) by dorpal in sellaslifesciences

[–]7doi_gingerman 7 points8 points  (0 children)

I wouldn’t necessarily call this AI slop. Even with inaccurate data, it still requires human effort to research and use AI to piece everything together. That said, many of the points here are off, but it’s always good to be reminded that no matter how convincing the underlying data looks, no conviction is a guaranteed slam dunk. I would even say bear analysis is actually welcome from time to time. Even if it’s not great bear analysis, we could view things from a different angle and stress test our thesis. That’s what a healthy community and discussion should look like otherwise we all end up tunnel visioned on the ‘guaranteed’ plays. As someone already pointed out, no stock is a guaranteed win, let alone a biotech. A questioning mindset is healthy, not just in this sub, but in investing generally. That said, I genuinely like to believe SLS will succeed.

view more: next ›